Cargando…
Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial
Background: Diabetic retinopathy (DR) is one of the most common and severe microvascular complications of diabetes mellitus (DM), which results in blindness among adults worldwide. Presently, the efficacy of drug treatments for diabetic retinopathy (DR) is not satisfactory, thus urgently necessitati...
Autores principales: | Jin, De, Zhang, Yuehong, Zhang, Yuqing, Huang, Wenjing, Meng, Xiang, Yang, Fan, Bao, Qi, Zhang, Meizhen, Yang, Yanan, Ni, Qing, Lian, Fengmei, Tong, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005869/ https://www.ncbi.nlm.nih.gov/pubmed/33790783 http://dx.doi.org/10.3389/fphar.2021.594308 |
Ejemplares similares
-
Pharmacokinetic study of Tangwang Mingmu granule for the management of diabetic retinopathy based on network pharmacology
por: Wang, Yucheng, et al.
Publicado: (2021) -
Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats
por: Chen, Mingxia, et al.
Publicado: (2017) -
Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials
por: Zhou, Rongrong, et al.
Publicado: (2021) -
Corrigendum: Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials
por: Zhou, Rongrong, et al.
Publicado: (2022) -
Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis
por: Zhang, Yuehong, et al.
Publicado: (2022)